Andrea Pautz

3.4k total citations · 1 hit paper
60 papers, 2.7k citations indexed

About

Andrea Pautz is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Andrea Pautz has authored 60 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 14 papers in Physiology and 13 papers in Immunology. Recurrent topics in Andrea Pautz's work include RNA Research and Splicing (18 papers), Nitric Oxide and Endothelin Effects (11 papers) and RNA modifications and cancer (9 papers). Andrea Pautz is often cited by papers focused on RNA Research and Splicing (18 papers), Nitric Oxide and Endothelin Effects (11 papers) and RNA modifications and cancer (9 papers). Andrea Pautz collaborates with scholars based in Germany, United States and Switzerland. Andrea Pautz's co-authors include Hartmut Kleinert, Katrin Linker, Petra Schwarz, Julia Art, Susanne A. Hahn, Ulrich Förstermann, Huige Li, M. Féchir, Andreas Daiber and Sebastian Altenhöfer and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Andrea Pautz

59 papers receiving 2.7k citations

Hit Papers

Regulation of the expression of inducible nitric oxide sy... 2004 2026 2011 2018 2004 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Pautz Germany 25 1.2k 628 607 337 281 60 2.7k
Motoyuki Kohjima Japan 29 1.2k 1.0× 744 1.2× 492 0.8× 237 0.7× 156 0.6× 104 3.4k
Yup Kang South Korea 30 1.3k 1.1× 537 0.9× 490 0.8× 279 0.8× 189 0.7× 99 3.5k
Alessandra K. Cardozo Belgium 37 1.8k 1.5× 705 1.1× 955 1.6× 342 1.0× 111 0.4× 68 6.4k
Ronit Shiri‐Sverdlov Netherlands 37 1.5k 1.3× 581 0.9× 601 1.0× 414 1.2× 351 1.2× 108 4.4k
Tomonaga Ichikawa Japan 22 1.3k 1.0× 339 0.5× 375 0.6× 284 0.8× 296 1.1× 47 2.3k
Morgan D. Fullerton Canada 31 2.7k 2.2× 1.2k 1.9× 617 1.0× 554 1.6× 224 0.8× 62 4.6k
Chandrashekhar R. Gandhi United States 35 945 0.8× 538 0.9× 452 0.7× 258 0.8× 149 0.5× 93 3.5k
Francisco Sobrino Spain 26 1.2k 1.0× 482 0.8× 523 0.9× 246 0.7× 216 0.8× 92 2.5k
Anath Shalev United States 36 2.7k 2.2× 826 1.3× 270 0.4× 506 1.5× 200 0.7× 76 4.7k
Jennifer Altomonte Germany 26 1.8k 1.5× 845 1.3× 271 0.4× 237 0.7× 206 0.7× 52 3.6k

Countries citing papers authored by Andrea Pautz

Since Specialization
Citations

This map shows the geographic impact of Andrea Pautz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Pautz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Pautz more than expected).

Fields of papers citing papers by Andrea Pautz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Pautz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Pautz. The network helps show where Andrea Pautz may publish in the future.

Co-authorship network of co-authors of Andrea Pautz

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Pautz. A scholar is included among the top collaborators of Andrea Pautz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Pautz. Andrea Pautz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tubbe, Ingrid, et al.. (2025). The RNA-binding protein KSRP reduces asthma-like characteristics in a murine model. Inflammation Research. 74(1). 54–54.
2.
Schumann, Sven, et al.. (2024). Effect of the antirheumatic medication methotrexate (MTX) on biomechanical compressed human periodontal ligament fibroblasts (hPDLFs). BMC Oral Health. 24(1). 329–329. 1 indexed citations
3.
Meineck, Myriam, et al.. (2023). A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy. Pharmacology & Therapeutics. 249. 108503–108503. 11 indexed citations
4.
Meineck, Myriam, Wilfried Roth, Till Opatz, et al.. (2023). The macrocyclic lactone oxacyclododecindione reduces fibrosis progression. Frontiers in Pharmacology. 14. 1200164–1200164. 2 indexed citations
5.
Meineck, Myriam, et al.. (2023). A Systematic Review on Renal Effects of Sglt2 Inhibitors in Rodent Models of Diabetic Nephropathy. SSRN Electronic Journal. 1 indexed citations
6.
Ihrig‐Biedert, Irmgard, et al.. (2022). A specific, non-immune system-related isoform of the human inducible nitric oxide synthase is expressed during differentiation of human stem cells into various cell types. Cell Communication and Signaling. 20(1). 47–47. 4 indexed citations
7.
Kleinert, Hartmut, et al.. (2022). The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis. Cells. 11(9). 1482–1482. 22 indexed citations
8.
Meineck, Myriam, et al.. (2021). Knockout of the KH-Type Splicing Regulatory Protein Drives Glomerulonephritis in MRL-Faslpr Mice. Cells. 10(11). 3167–3167. 8 indexed citations
9.
Witte, Ines, Andrea Schüler, Piyush More, et al.. (2021). Deficiency of Antioxidative Paraoxonase 2 (Pon2) Leads to Increased Number of Phenotypic LT‐HSCs and Disturbed Erythropoiesis. Oxidative Medicine and Cellular Longevity. 2021(1). 3917028–3917028. 3 indexed citations
10.
Ihrig‐Biedert, Irmgard, Matthias Oelze, Swenja Kröller‐Schön, et al.. (2020). NOX2ko Mice Show Largely Increased Expression of a Mutated NOX2 mRNA Encoding an Inactive NOX2 Protein. Antioxidants. 9(11). 1043–1043. 4 indexed citations
11.
Beyer, Mandy, A Romański, Andrea Pautz, et al.. (2019). HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1. Cancers. 11(10). 1436–1436. 28 indexed citations
12.
Jäckel, Sven, Christoph Reinhardt, Kerstin Jurk, et al.. (2015). Anti-Inflammatory and Anti-Thrombotic Effects of the Fungal Metabolite Galiellalactone in Apolipoprotein E-Deficient Mice. PLoS ONE. 10(6). e0130401–e0130401. 6 indexed citations
13.
Wu, Zhixiong, Matthias Oelze, Daniel Siuda, et al.. (2014). Endothelial Dysfunction in Tristetraprolin-deficient Mice Is Not Caused by Enhanced Tumor Necrosis Factor-α Expression. Journal of Biological Chemistry. 289(22). 15653–15665. 18 indexed citations
16.
Torzewski, Michael, Philip Wenzel, Hartmut Kleinert, et al.. (2011). Chronic Inflammatory Cardiomyopathy of Interferon γ–Overexpressing Transgenic Mice Is Mediated by Tumor Necrosis Factor-α. American Journal Of Pathology. 180(1). 73–81. 20 indexed citations
17.
Oelze, Matthias, Maike Knorr, Richard E. Schell, et al.. (2011). Regulation of Human Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity by Electrophiles in Vitro. Journal of Biological Chemistry. 286(11). 8893–8900. 35 indexed citations
18.
Pautz, Andrea, Katrin Linker, Sebastian Altenhöfer, et al.. (2008). Similar Regulation of Human Inducible Nitric-oxide Synthase Expression by Different Isoforms of the RNA-binding Protein AUF1. Journal of Biological Chemistry. 284(5). 2755–2766. 28 indexed citations
19.
Bros, Matthias, et al.. (2003). The Human Fascin Gene Promoter Is Highly Active in Mature Dendritic Cells Due to a Stage-Specific Enhancer. The Journal of Immunology. 171(4). 1825–1834. 58 indexed citations
20.
Pautz, Andrea, et al.. (2001). Interleukin-1β Induces Chronic Activation and de Novo Synthesis of Neutral Ceramidase in Renal Mesangial Cells. Journal of Biological Chemistry. 276(38). 35382–35389. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026